The Shocking Revelation of 7-Nitro-1,2,3,4-tetrahydroisoquinoline

If you are interested in 42923-79-5, you can contact me at any time and look forward to more communication. name: 7-Nitro-1,2,3,4-tetrahydroisoquinoline

New Advances in Chemical Research in 2021. In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 42923-79-5, name is 7-Nitro-1,2,3,4-tetrahydroisoquinoline, introducing its new discovery. name: 7-Nitro-1,2,3,4-tetrahydroisoquinoline

The invention relates to a novel compound which is represented by the formula (1) and has an excellent platelet aggregation inhibiting action based on fibrinogen antagonism. The platelet aggregation inhibitor containing the compound of the formula (1) as an effective ingredient are effective for prevention and curing of thrombosis and restenosis or reocclusion after percutaneous transluminal coronary angioplasty or percutaneous transluminal coronary recanalization.

If you are interested in 42923-79-5, you can contact me at any time and look forward to more communication. name: 7-Nitro-1,2,3,4-tetrahydroisoquinoline

Reference:
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem